Form 4 for PASG Passage BIO, Inc.
Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-22 · accession 0001209191-22-058795 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-25 | 2022-11-22 | PASG | Fotopoulos Alexandros | Chief Technical Off | M - OptEx | $0.00 | +12.5K | 24.0K | +109% | $0 |
| D | 2022-11-25 | 2022-11-22 | PASG | Fotopoulos Alexandros | Chief Technical Off | S - Sale+OE | $1.33 | -3,720 | 20.2K | -16% | -$4,948 |
| D | 2022-11-25 | 2022-11-22 | PASG | Fotopoulos Alexandros | Chief Technical Off | M - OptEx | $0.00 | -12.5K | 37.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-22 | M | A | 12,500 | $0.00 | 23,965 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F2) The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). |
| 2 | Common | Common Stock | 2022-11-22 | S | D | 3,720 | $1.33 | 20,245 | D | — | — | (F2) The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). |
| 3 | Derivative | Restricted Stock Units | 2022-11-22 | M | D | 12,500 | $0.00 | 37,500 | D | — · — to — | 12,500 Common Stock | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F5) 1/4 of the RSUs vested on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. (F6) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |